Skip to main content
Clinical Trials/NCT05160675
NCT05160675
Completed
Not Applicable

Nutrition, Microbiome and Bone Health During Early Life Related to Health

Société des Produits Nestlé (SPN)1 site in 1 country2,760 target enrollmentSeptember 3, 2021
ConditionsHealthy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy
Sponsor
Société des Produits Nestlé (SPN)
Enrollment
2760
Locations
1
Primary Endpoint
dietary factors
Status
Completed
Last Updated
5 months ago

Overview

Brief Summary

The aim of the study is to establish the longitudinal microbiome and bone trajectories from birth to 3 years, and to evaluate the influence of nutrition on these trajectories.

Detailed Description

The main objective of the study is to understand the influence of nutrition and dietary patterns on microbiome and bone trajectories during early life. Specific research objectives are: * Establish the reference trajectories of gut microbiome maturation index and bone development in healthy Chinese children aged 0-3years * Assess the impact of early life nutrition on gut microbiome trajectory * Investigate the influence of microbiome, early life parameters and nutritional parameters on bone health

Registry
clinicaltrials.gov
Start Date
September 3, 2021
End Date
September 8, 2025
Last Updated
5 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Société des Produits Nestlé (SPN)
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • It is important to carefully consider whether a subject is suitable for enrollment into this observational study. Fulfillment of the inclusion and exclusion criteria for each subject will be documented by a qualified member of the investigative staff before any subject is enrolled.
  • Healthy infants who fulfill all the following inclusion criteria will be included:
  • Having obtained his/her parents' (or his/her legally accepted representative's \[LAR's\]) written informed consent and having evidence of personally signed and dated informed consent document indicating that the subject's parents/LAR have been informed of all pertinent aspects of the study.
  • Subject's parent(s)/LAR is of legal age of consent, is willing and able to fulfill the requirements of the study protocol.
  • For group 1, healthy infants aged ≤ 10 days after birth (date of birth = Day 0).
  • For group 2, healthy infants with maximum age of 6 months
  • Full-term gestational birth (≥ 37 and ≤ 42 weeks).
  • Subject's parent(s)/LAR is able to be contacted directly by telephone throughout the study.
  • Both parents registered have a fixed work and / or residence within their jurisdiction.

Exclusion Criteria

  • Complicated pregnancy (e.g., preeclampsia, gestational diabetes, bowel disease) as assessed by medical interview/ medical record when available
  • Infant's parents/LAR not willing and/or not able to comply with scheduled visits and the requirements of the study protocol
  • Currently participating or having participated in another clinical trial within 4 weeks prior to trial start.

Outcomes

Primary Outcomes

dietary factors

Time Frame: Group 1: 0-1 year, Group 2: 0.5-3 years

derived from food diaries of the types of complementary feeding, the food consumption, the nutrient intakes, the food source of nutrients, the dietary patterns

gut microbiome

Time Frame: Group 1: 0-1 year, Group 2: 0.5-3 years

microbiome maturation index derived from microbial composition, bacteria function, metabolites

bone development

Time Frame: Group 1: 0-1 year, Group 2: 0.5-3 years

bone tibia speed of sounds (SOS) (meter / second) using ultrasound

bone health

Time Frame: Group 1: 0-1 year, Group 2: 0.5-3 years

Bone tibia length using ruler (cm)

dietary intakes and health outcomes

Time Frame: Group 1: 0-1 year, Group 2: 0.5-3 years

derived from infant questionnaires and their food diaries of the types of complementary feeding, the food consumption, the nutrient intakes, the food source of nutrients, the dietary patterns

Secondary Outcomes

  • Urinary markers of bone metabolism(Group 1: 0-1 year, Group 2: 0.5-3 years)
  • Gut microbiome(Group 1: 0-1 year, Group 2: 0.5-3 years)
  • breast milk composition(Group 1: 0-3 months)

Study Sites (1)

Loading locations...

Similar Trials